4D Molecular Therapeutics, Inc. (FDMT)

FDMT is trading above its short-, medium- and long-term moving averages, showing broad bullish alignment while ADX above 28 indicates a strengthening trend. Momentum readings are constructive with RSI in the upper range and a mildly positive MACD, though short-term momentum recently showed slight softness. Volatility is moderate with ATR around 6.5%, and the classic pivot is close to current price near 14.64, offering a nearby reference. However, on-balance volume reads large but is flagged as not confirming, which tempers conviction. Technical takeaway: strong buy stance reflects broad moving-average support and trend strength, tempered by mixed volume confirmation.